<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Saudi J Anaesth</journal-id><journal-id journal-id-type="iso-abbrev">Saudi J Anaesth</journal-id><journal-id journal-id-type="publisher-id">SJA</journal-id><journal-title-group><journal-title>Saudi Journal of Anaesthesia</journal-title></journal-title-group><issn pub-type="ppub">1658-354X</issn><issn pub-type="epub">0975-3125</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25538518</article-id><article-id pub-id-type="pmc">4268525</article-id><article-id pub-id-type="publisher-id">SJA-8-36</article-id><article-id pub-id-type="doi">10.4103/1658-354X.144068</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Patient-controlled sedation with propofol/remifentanil versus propofol/alfentanil for patients undergoing outpatient colonoscopy, a randomized, controlled double-blind study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Sultan</surname><given-names>Sherif S.</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"/></contrib></contrib-group><aff id="aff1"><italic>Department of Anesthesia and Intensive Care, Faculty of Medicine, Ain Shams University, Cairo, Egypt</italic></aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Sherif S. Sultan, 24, Muhammad Al-Maqreef Street, Nasr City, Cairo, Egypt. E-mail: <email xlink:href="sherif_sultan@yahoo.com">sherif_sultan@yahoo.com</email></corresp></author-notes><pub-date pub-type="ppub"><month>11</month><year>2014</year></pub-date><volume>8</volume><issue>Suppl 1</issue><fpage>S36</fpage><lpage>S40</lpage><permissions><copyright-statement>Copyright: &#x000a9; Saudi Journal of Anaesthesia</copyright-statement><copyright-year>2014</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title>Context:</title><p>Many techniques are used for sedation of colonoscopies. Patient-controlled sedation (PCS) is utilizing many drugs or drug combinations.</p></sec><sec id="st2"><title>Aims:</title><p>The aim of this study is to compare the safety and feasibility of propofol/remifentanil versus propofol/alfentanil given to sedate patients undergoing outpatient colonoscopies through a patient-controlled technique.</p></sec><sec id="st3"><title>Settings and Design:</title><p>Controlled randomized and double-blind study.</p></sec><sec id="st4"><title>Materials and Methods:</title><p>A total of 80 patients were randomly divided into two groups; PA group received a combination of propofol/alfentanil and PR group received propofol/remifentanil combination. Patients were monitored for heart rate (HR), blood pressure (BP), oxygen saturation, and Ramsay sedation scale (RSS). Times of the following events were recorded; initiation of sedation, insertion and removal of the colonoscope, recovery and discharge. Five intervals were calculated; time to sedation, procedure time, postprocedure time, procedure room time, and postanesthesia care unit (PACU) time. Endoscopist and patient satisfaction scores were obtained.</p></sec><sec id="st5"><title>Statistical Analysis Used:</title><p>Unpaired Student's t-test was used to compare between the two groups. Paired Student's t-test was used to compare baseline readings with readings after 30 min of sedation in the same group when needed.</p></sec><sec id="st6"><title>Results:</title><p>Both groups showed slowing of the HR and decrease in mean arterial BP. HR and mean arterial BP were significantly lower 5 and 10 min after initiation of sedation in PR group when compared with PA group. Both HR and mean arterial BP returned to presedation readings 30 min after initiation of sedation in PR group but not in PA group. No differences between the two groups concerning oxygen saturation, RSS, endoscopist and patient satisfaction scores. Postprocedure and PACU times were significantly prolonged in PA group.</p></sec><sec id="st7"><title>Conclusion:</title><p>PCS with either remifentanil/propofol or alfentanil/propofol for patients undergoing outpatient colonoscopy is safe and feasible. Remifentanil/proofol has more beneficial advantages in this setting secondary to its more rapid clearance.</p></sec></abstract><kwd-group><kwd><italic>Alfentanil</italic></kwd><kwd><italic>colonoscopy</italic></kwd><kwd><italic>patient-controlled sedation</italic></kwd><kwd><italic>remifentanil</italic></kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>INTRODUCTION</title><p>Colorectal cancer is the third most common cancer worldwide constituting about 9% of all cancer incidence.[<xref rid="ref1" ref-type="bibr">1</xref>] Colonoscopy is a sensitive screening tool and has the potential to prevent about 65% of colorectal cancer cases.[<xref rid="ref2" ref-type="bibr">2</xref>] In 2002, it was estimated that about 14.2 million colonoscopies were performed in US.[<xref rid="ref3" ref-type="bibr">3</xref>]</p><p>In a study conducted over 1187 patients subjected to colonoscopies, although 94% of patients were sedated; however, 23% of patients judged that colonoscopy was more uncomfortable than expected with 10% reported it as very uncomfortable.[<xref rid="ref4" ref-type="bibr">4</xref>] Many sedation techniques were utilized during colonoscopies including intermittent bolus administration,[<xref rid="ref5" ref-type="bibr">5</xref><xref rid="ref6" ref-type="bibr">6</xref>] intravenous (IV) continuous infusion[<xref rid="ref7" ref-type="bibr">7</xref>] and patient-controlled administration. For patient-controlled sedation (PCS) propofol,[<xref rid="ref8" ref-type="bibr">8</xref><xref rid="ref9" ref-type="bibr">9</xref>] midazolam/fentanyl,[<xref rid="ref10" ref-type="bibr">10</xref>] propofol/alfentanil[<xref rid="ref6" ref-type="bibr">6</xref><xref rid="ref11" ref-type="bibr">11</xref><xref rid="ref12" ref-type="bibr">12</xref><xref rid="ref13" ref-type="bibr">13</xref><xref rid="ref14" ref-type="bibr">14</xref>] and propofol/remifentanil[<xref rid="ref10" ref-type="bibr">10</xref>] were all tried with different levels of success.</p><p>Adding propofol to alfentanil increases sedation, potentiates analgesia, and decreases postoperative nausea and vomiting, with no increase in respiratory depression.[<xref rid="ref15" ref-type="bibr">15</xref>] Alfentanil has a relatively long half-life compared with propofol. Remifentanil has a shorter half-life, comparative duration of effect to propofol, and lacks residual postoperative sedation.[<xref rid="ref16" ref-type="bibr">16</xref>] These properties may render remifentanil more suitable than alfentanil when given with propofol in settings of outpatient colonoscopy.</p><p>This study was aimed to compare the safety and feasibility of a combination of propofol/remifentanil with that of propofol/alfentanil for patients undergoing outpatient colonoscopy utilizing PCS.</p></sec><sec sec-type="materials|methods" id="sec1-2"><title>MATERIALS AND METHODS</title><p>After obtaining approval of Research Ethics Committee, this controlled randomized double-blinded study was conducted. Inclusion criteria included patients aged 18-65 years, American Society of Anesthesiologists classification I, II or III and scheduled for elective outpatient colonoscopy. Written consents were obtained from all patients. Exclusion criteria included known allergy to study drugs, neuropsychiatric disease, advanced heart or respiratory disease, alcohol or drug abuse, gastrointestinal bleeding, pregnancy, patients with history of colonic surgery and patients unable to use PCS.</p><p>Eighty patients were randomly assigned to one of two groups; PA group received a combination of propofol/alfentanil and PR group received propofol/remifentanil combination for PCS during colonoscopy. Patients were randomized by sequentially numbered envelopes. The anesthesiologist, nurse and endoscopist were all blind to the drug mixed with propofol. All procedures were conducted by the same endoscopist. The mixture was prepared by the hospital pharmacist just before the start of the procedure. The mixture was prepared in a 50-ml syringe that is connected to a separate IV cannula with primed IV tubing. Each syringe contained 48 ml of propofol 1% plus 2 ml of either 1 mg of alfentanil in PA group or 0.5 mg of remifentanil in PR group. A patient-controlled analgesia pump (Perfusor fmTM, B. Braun, Germany) was used to deliver PCS. The machine was adjusted to give no background infusion, bolus of 0.75 ml over 10 s with no lockout time. Patients were instructed to push the demand button 4 times before the colonoscope is inserted then whenever they feel any discomfort.</p><p>All patients received 3 L/min of oxygen via nasal cannula. The anesthesiologist intervened if the patient experienced bradycardia (heart rate [HR] &#x0003c;50/min), hypotension (systolic blood pressure [BP] &#x0003c;90 mmHg), desaturation (oxygen saturation [SpO<sub>2</sub>] &#x0003c;90%) or the patient is not responsive to tactile stimulation. Patients were monitored by a trained nurse that collected data just before the start of sedation (time 0), 1 min after the start of sedation and then every 5 min for HR, mean arterial BP, SpO<sub>2</sub> and level of sedation using Ramsay sedation scale (RSS) [<xref ref-type="table" rid="T1">Table 1</xref>].</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Ramsay sedation scale</p></caption><graphic xlink:href="SJA-8-36-g001"/></table-wrap><p>Times of the following events were recorded; initiation of sedation (time of the patient pushing demand button 4 times), insertion of colonoscope (judged when RSS reach 3-4), removal of colonoscope, recovery time (RSS become 2, HR, BP and oxygen saturation are within 20% of basal readings), and discharge time (patient reaches Aldrete score [<xref ref-type="table" rid="T2">Table 2</xref>] of 9 or more). From these five events, five intervals were calculated; time to sedation (from initiation of sedation to insertion of colonoscope), procedure time (from insertion to removal of colonoscope), postprocedure time (from removal of colonoscope to discharge time), procedure room time (from initiation of sedation to recovery time), and postanesthesia care unit (PACU) time (from recovery time to discharge time).</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Aldrete score</p></caption><graphic xlink:href="SJA-8-36-g002"/></table-wrap><p>Immediately after the procedure ended, the endoscopist was asked to report his satisfaction in a scale from 1 to 10 (1: Not satisfied and 10: Very satisfied). Just before discharge, patients were asked to report their satisfaction clearly concerning only sedation and analgesia in a scale from 1 to 10 (1: Not satisfied and 10: Very satisfied).</p><p>Data were presented as mean &#x000b1; standard deviation. Unpaired Student's t-test was used for comparison between the two groups. Paired Student's t-test was used to compare baseline readings (time 0) to readings after 30 min from initiation of sedation within the same group for both HR and mean arterial BP. Statistical analysis was performed using SPSS statistical package (SPSS Inc., Chicago, Il, USA) version 15 for windows. <italic>P</italic> &#x0003c; 0.05 was considered to be statistically significant.</p></sec><sec sec-type="results" id="sec1-3"><title>RESULTS</title><p>There were no differences between groups concerning demographic data and number of patients subjected to polypectomies [<xref ref-type="table" rid="T3">Table 3</xref>].</p><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Demographic data and number of patients subjected to polypectomies in the two groups</p></caption><graphic xlink:href="SJA-8-36-g003"/></table-wrap><p>Figures <xref ref-type="fig" rid="F1">1</xref> and <xref ref-type="fig" rid="F2">2</xref> show changes in HR and mean arterial pressure (MAP) consecutively. Both groups showed slowing in HR and decrease in MAP after the start of sedation. HR and MAP were significantly lower in PR group when compared with PA group 5 and 10 min after the start of sedation. HR and MAP returned to presedation values 30 min after the start of sedation in PR group while stayed at significantly lower values in PA group when compared with presedation values. <xref ref-type="fig" rid="F3">Figure 3</xref> shows changes in arterial oxygen saturation. There were no statistically significant changes between groups at anytime. Eight patients in PA group and six in PR group suffered desaturation but no one needed bag-mask ventilation or endotracheal intubation. <xref ref-type="fig" rid="F4">Figure 4</xref> shows changes in RSS. There were no statistically significant changes between groups at anytime.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Heart rate changes during procedure. *<italic>P</italic> &#x0003c; 0.05, significant inter-group differences. #<italic>P</italic> &#x0003c; 0.05, significant changes compared with time 0 reading in the same group</p></caption><graphic xlink:href="SJA-8-36-g004"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><p>Mean arterial pressure changes during procedure. *<italic>P</italic> &#x0003c; 0.05, significant inter-group differences. #<italic>P</italic> &#x0003c; 0.05, significant changes compared with time 0 reading in the same group</p></caption><graphic xlink:href="SJA-8-36-g005"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><p>Arterial oxygen saturation changes during procedure</p></caption><graphic xlink:href="SJA-8-36-g006"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><p>Ramsay sedation scale changes during procedure</p></caption><graphic xlink:href="SJA-8-36-g007"/></fig><p><xref ref-type="table" rid="T4">Table 4</xref> shows different times calculated during the study. There were statistically significant differences in postprocedure and PACU times favoring shorter times in PR group. <xref ref-type="table" rid="T4">Table 4</xref> also contains satisfaction scores of the endoscopist and patients. Both showed no differences.</p><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>Times calculated during the study and satisfaction scores of the endoscopist and patients</p></caption><graphic xlink:href="SJA-8-36-g008"/></table-wrap></sec><sec sec-type="discussion" id="sec1-4"><title>DISCUSSION</title><p>Colonoscopy is considered the most accurate and the most commonly used procedure to image the large bowel, especially when colorectal cancer screening and surveillance of adenomas are considered.[<xref rid="ref17" ref-type="bibr">17</xref><xref rid="ref18" ref-type="bibr">18</xref><xref rid="ref19" ref-type="bibr">19</xref>] Propofol is widely used for sedation during the performance of different procedures. When propofol is used as a sole agent, large doses may be needed to tolerate some invasive procedures. Myocardial depression and peripheral vasodilation may follow. With higher doses, hypotension, respiratory depression, and decreased upper airway protective reflex activity can be life-threatening.[<xref rid="ref20" ref-type="bibr">20</xref>] Moreover, propofol lacks analgesic properties.</p><p>Adding opioids to propofol has many advantages. It decreases pain and discomfort during the performance of the procedure. It also decreases pain arising from propofol injection. Propofol in its turns decreases nausea and vomiting due to opioids. Moreover, total amounts of both drugs decrease and recovery is more rapid.[<xref rid="ref21" ref-type="bibr">21</xref>]</p><p>Many opioids were added to propofol with different degrees of success. Fentanyl,[<xref rid="ref20" ref-type="bibr">20</xref>] alfentanil,[<xref rid="ref11" ref-type="bibr">11</xref><xref rid="ref12" ref-type="bibr">12</xref><xref rid="ref20" ref-type="bibr">20</xref>] sufentanil,[<xref rid="ref22" ref-type="bibr">22</xref><xref rid="ref23" ref-type="bibr">23</xref>] and remifentanil[<xref rid="ref10" ref-type="bibr">10</xref><xref rid="ref24" ref-type="bibr">24</xref>] were all used. Alfentanil is less lipid soluble than fentanyl. This allows less tissue accumulation and therefore greater binding of plasma concentrations to opioid receptors and more rapid onset of effects.[<xref rid="ref25" ref-type="bibr">25</xref><xref rid="ref26" ref-type="bibr">26</xref>] Remifentanil may have advantages over alfentanil because of its shorter half-life, comparative duration of effect to propofol, and lack of residual postoperative sedation.[<xref rid="ref16" ref-type="bibr">16</xref>]</p><p>Egan <italic>et al</italic>. stated that alfentanil and remifentanil have many similarities. Pharmacokinetically, the two drugs are similar in terms of steady-state distribution volume but remifentanil's central clearance is substantially greater (2.9 vs. 0.36 L/min). Terminal half-life for remifentanil in the same study was 35.1 min compared with 94.5 min for alfentanil resulting in faster decline of blood concentration after discontinuation of an infusion. Pharmacodynamically, the drugs are similar in terms of the time required for equilibration between blood and the effect-site concentrations.[<xref rid="ref27" ref-type="bibr">27</xref>] This similarity explains the overall few statistically significant differences between the two groups in the present study. Still, differences in pharmacokinetics and pharmacodynamics between the two drugs can explain most of results in the present study.</p><p>When effects of a drug could be terminated by the end of the procedure, this drug will be very beneficial in states of outpatient settings. This goes very well with remifentanil when concerning performance of colonoscopies. Known that colonoscopy is usually not inducing postprocedural pain except if complicated, makes remifentanil a more suitable choice when mixed with propofol for PCS of cases of outpatient colonoscopy.</p><p>In the present study, both mixtures seemed safe and feasible. It is well-known that both alfentanil and remifentanil induce bradycardia and hypotension.[<xref rid="ref28" ref-type="bibr">28</xref>] These changes were evident in both groups with significant slowing of the HR and lowering of BP with PR group when compared with PA group. However, no medications were used to treat bradycardia or hypotension. Although lockout was zero and bolus injection time was only 10 s which might allow easy overdosing, respiratory depression did not happen. Oxygen desaturation was recorded is the present study in 14 cases. Both groups were almost equally affected. Patients did not need positive pressure ventilation reflecting the feasibility of sedation with these drugs. This was reflected on the endoscopist satisfaction for both groups. Other factors affected the endoscopist satisfaction were a short time needed for sedation and considerable procedure room time. Patient satisfaction was high in both groups. Administration of drugs through PCS is an important factor to increase patient satisfaction.[<xref rid="ref29" ref-type="bibr">29</xref>] It allows the patient to self-administer the exact amount of anesthetics required to treat varying degrees of pain and discomfort.[<xref rid="ref21" ref-type="bibr">21</xref>]</p></sec><sec sec-type="conclusion" id="sec1-5"><title>CONCLUSION</title><p>Patient-controlled sedation with either propofol/remifentanil or propofol/alfentanil is safe and feasible technique of sedation in settings of outpatient colonoscopy. Propofol/remifentanil has more beneficial advantages over propofol/alfentanil due to more rapid clearance of remifentanil compared with alfentanil.</p></sec></body><back><fn-group><fn fn-type="supported-by"><p><bold>Source of Support:</bold> Nil</p></fn><fn fn-type="conflict"><p><bold>Conflict of Interest:</bold> None declared.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyle</surname><given-names>P</given-names></name><name><surname>Langman</surname><given-names>JS</given-names></name></person-group><article-title>ABC of colorectal cancer: Epidemiology</article-title><source>BMJ</source><year>2000</year><volume>321</volume><fpage>805</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">11009523</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brenner</surname><given-names>H</given-names></name><name><surname>Chang-Claude</surname><given-names>J</given-names></name><name><surname>Seiler</surname><given-names>CM</given-names></name><name><surname>St&#x000fc;rmer</surname><given-names>T</given-names></name><name><surname>Hoffmeister</surname><given-names>M</given-names></name></person-group><article-title>Potential for colorectal cancer prevention of sigmoidoscopy versus colonoscopy: Population-based case control study</article-title><source>Cancer Epidemiol Biomarkers Prev</source><year>2007</year><volume>16</volume><fpage>494</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">17337649</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seeff</surname><given-names>LC</given-names></name><name><surname>Richards</surname><given-names>TB</given-names></name><name><surname>Shapiro</surname><given-names>JA</given-names></name><name><surname>Nadel</surname><given-names>MR</given-names></name><name><surname>Manninen</surname><given-names>DL</given-names></name><name><surname>Given</surname><given-names>LS</given-names></name><etal/></person-group><article-title>How many endoscopies are performed for colorectal cancer screening? Results from CDC's survey of endoscopic capacity</article-title><source>Gastroenterology</source><year>2004</year><volume>127</volume><fpage>1670</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">15578503</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Jonge</surname><given-names>V</given-names></name><name><surname>Sint</surname><given-names>Nicolaas J</given-names></name><name><surname>Lalor</surname><given-names>EA</given-names></name><name><surname>Wong</surname><given-names>CK</given-names></name><name><surname>Walters</surname><given-names>B</given-names></name><name><surname>Bala</surname><given-names>A</given-names></name><etal/></person-group><article-title>A prospective audit of patient experiences in colonoscopy using the Global Rating Scale: A cohort of 1,187 patients</article-title><source>Can J Gastroenterol</source><year>2010</year><volume>24</volume><fpage>607</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">21037990</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cinar</surname><given-names>K</given-names></name><name><surname>Yakut</surname><given-names>M</given-names></name><name><surname>Ozden</surname><given-names>A</given-names></name></person-group><article-title>Sedation with midazolam versus midazolam plus meperidine for routine colonoscopy: A prospective, randomized, controlled study</article-title><source>Turk J Gastroenterol</source><year>2009</year><volume>20</volume><fpage>271</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">20084571</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bright</surname><given-names>E</given-names></name><name><surname>Roseveare</surname><given-names>C</given-names></name><name><surname>Dalgleish</surname><given-names>D</given-names></name><name><surname>Kimble</surname><given-names>J</given-names></name><name><surname>Elliott</surname><given-names>J</given-names></name><name><surname>Shepherd</surname><given-names>H</given-names></name></person-group><article-title>Patient-controlled sedation for colonoscopy: A randomized trial comparing patient-controlled administration of propofol and alfentanil with physician-administered midazolam and pethidine</article-title><source>Endoscopy</source><year>2003</year><volume>35</volume><fpage>683</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">12929065</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mart&#x000ed;nez</surname><given-names>JF</given-names></name><name><surname>Aparicio</surname><given-names>JR</given-names></name><name><surname>Compa&#x000f1;y</surname><given-names>L</given-names></name><name><surname>Ruiz</surname><given-names>F</given-names></name><name><surname>G&#x000f3;mez-Escolar</surname><given-names>L</given-names></name><name><surname>Mozas</surname><given-names>I</given-names></name><etal/></person-group><article-title>Safety of continuous propofol sedation for endoscopic procedures in elderly patients</article-title><source>Rev Esp Enferm Dig</source><year>2011</year><volume>103</volume><fpage>76</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">21366368</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heiman</surname><given-names>DR</given-names></name><name><surname>Tolliver</surname><given-names>BA</given-names></name><name><surname>Weis</surname><given-names>FR</given-names></name><name><surname>O&#x02019;Brien</surname><given-names>BL</given-names></name><name><surname>DiPalma</surname><given-names>JA</given-names></name></person-group><article-title>Patient-controlled anesthesia for colonoscopy using propofol: Results of a pilot study</article-title><source>South Med J</source><year>1998</year><volume>91</volume><fpage>560</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">9634119</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>JM</given-names></name><name><surname>Kong</surname><given-names>CF</given-names></name><name><surname>Nyam</surname><given-names>D</given-names></name></person-group><article-title>Patient-controlled sedation with propofol for colonoscopy</article-title><source>Gastrointest Endosc</source><year>2001</year><volume>54</volume><fpage>8</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">11427834</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mandel</surname><given-names>JE</given-names></name><name><surname>Tanner</surname><given-names>JW</given-names></name><name><surname>Lichtenstein</surname><given-names>GR</given-names></name><name><surname>Metz</surname><given-names>DC</given-names></name><name><surname>Katzka</surname><given-names>DA</given-names></name><name><surname>Ginsberg</surname><given-names>GG</given-names></name><etal/></person-group><article-title>A randomized, controlled, double-blind trial of patient-controlled sedation with propofol/remifentanil versus midazolam/fentanyl for colonoscopy</article-title><source>Anesth Analg</source><year>2008</year><volume>106</volume><fpage>434</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">18227297</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roseveare</surname><given-names>C</given-names></name><name><surname>Seavell</surname><given-names>C</given-names></name><name><surname>Patel</surname><given-names>P</given-names></name><name><surname>Criswell</surname><given-names>J</given-names></name><name><surname>Kimble</surname><given-names>J</given-names></name><name><surname>Jones</surname><given-names>C</given-names></name><etal/></person-group><article-title>Patient-controlled sedation and analgesia, using propofol and alfentanil, during colonoscopy: A prospective randomized controlled trial</article-title><source>Endoscopy</source><year>1998</year><volume>30</volume><fpage>768</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">9932756</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roseveare</surname><given-names>C</given-names></name><name><surname>Seavell</surname><given-names>C</given-names></name><name><surname>Patel</surname><given-names>P</given-names></name><name><surname>Criswell</surname><given-names>J</given-names></name><name><surname>Shepherd</surname><given-names>H</given-names></name></person-group><article-title>Patient-controlled sedation with propofol and alfentanil during colonoscopy: A pilot study</article-title><source>Endoscopy</source><year>1998</year><volume>30</volume><fpage>482</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">9693897</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>DW</given-names></name><name><surname>Li</surname><given-names>AC</given-names></name><name><surname>Ko</surname><given-names>CW</given-names></name><name><surname>Chu</surname><given-names>DW</given-names></name><name><surname>Chan</surname><given-names>KC</given-names></name><name><surname>Poon</surname><given-names>CM</given-names></name><etal/></person-group><article-title>Use of a variable-stiffness colonoscope decreases the dose of patient-controlled sedation during colonoscopy: A randomized comparison of 3 colonoscopes</article-title><source>Gastrointest Endosc</source><year>2007</year><volume>65</volume><fpage>424</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">17321243</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>DW</given-names></name><name><surname>Chan</surname><given-names>AC</given-names></name><name><surname>Wong</surname><given-names>SK</given-names></name><name><surname>Li</surname><given-names>AC</given-names></name><name><surname>Sze</surname><given-names>TS</given-names></name><name><surname>Chung</surname><given-names>SC</given-names></name></person-group><article-title>The safety, feasibility, and acceptability of patient-controlled sedation for colonoscopy: Prospective study</article-title><source>Hong Kong Med J</source><year>2004</year><volume>10</volume><fpage>84</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">15075427</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pavlin</surname><given-names>DJ</given-names></name><name><surname>Coda</surname><given-names>B</given-names></name><name><surname>Shen</surname><given-names>DD</given-names></name><name><surname>Tschanz</surname><given-names>J</given-names></name><name><surname>Nguyen</surname><given-names>Q</given-names></name><name><surname>Schaffer</surname><given-names>R</given-names></name><etal/></person-group><article-title>Effects of combining propofol and alfentanil on ventilation, analgesia, sedation, and emesis in human volunteers</article-title><source>Anesthesiology</source><year>1996</year><volume>84</volume><fpage>23</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">8572340</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>S&#x000e1; R&#x000ea;go</surname><given-names>MM</given-names></name><name><surname>Inagaki</surname><given-names>Y</given-names></name><name><surname>White</surname><given-names>PF</given-names></name></person-group><article-title>Remifentanil administration during monitored anesthesia care: Are intermittent boluses an effective alternative to a continuous infusion?</article-title><source>Anesth Analg</source><year>1999</year><volume>88</volume><fpage>518</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">10071997</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rex</surname><given-names>DK</given-names></name><name><surname>Petrini</surname><given-names>JL</given-names></name><name><surname>Baron</surname><given-names>TH</given-names></name><name><surname>Chak</surname><given-names>A</given-names></name><name><surname>Cohen</surname><given-names>J</given-names></name><name><surname>Deal</surname><given-names>SE</given-names></name><etal/></person-group><article-title>Quality indicators for colonoscopy</article-title><source>Am J Gastroenterol</source><year>2006</year><volume>101</volume><fpage>873</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">16635231</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harewood</surname><given-names>GC</given-names></name><name><surname>Lieberman</surname><given-names>DA</given-names></name></person-group><article-title>Colonoscopy practice patterns since introduction of medicare coverage for average-risk screening</article-title><source>Clin Gastroenterol Hepatol</source><year>2004</year><volume>2</volume><fpage>72</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">15017635</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lieberman</surname><given-names>DA</given-names></name><name><surname>Holub</surname><given-names>J</given-names></name><name><surname>Eisen</surname><given-names>G</given-names></name><name><surname>Kraemer</surname><given-names>D</given-names></name><name><surname>Morris</surname><given-names>CD</given-names></name></person-group><article-title>Utilization of colonoscopy in the United States: Results from a national consortium</article-title><source>Gastrointest Endosc</source><year>2005</year><volume>62</volume><fpage>875</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">16301030</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>T&#x000fc;rk</surname><given-names>H&#x0015e;</given-names></name><name><surname>Aydo&#x0011f;mu&#x0015f;</surname><given-names>M</given-names></name><name><surname>&#x000dc;nsal</surname><given-names>O</given-names></name><name><surname>K&#x000f6;ksal</surname><given-names>HM</given-names></name><name><surname>A&#x000e7;ik</surname><given-names>ME</given-names></name><name><surname>Oba</surname><given-names>S</given-names></name></person-group><article-title>Sedation-analgesia in elective colonoscopy: Propofol-fentanyl versus propofol-alfentanil</article-title><source>Rev Bras Anestesiol</source><year>2013</year><volume>63</volume><fpage>352</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">23931250</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joo</surname><given-names>HS</given-names></name><name><surname>Perks</surname><given-names>WJ</given-names></name><name><surname>Kataoka</surname><given-names>MT</given-names></name><name><surname>Errett</surname><given-names>L</given-names></name><name><surname>Pace</surname><given-names>K</given-names></name><name><surname>Honey</surname><given-names>RJ</given-names></name></person-group><article-title>A comparison of patient-controlled sedation using either remifentanil or remifentanil-propofol for shock wave lithotripsy</article-title><source>Anesth Analg</source><year>2001</year><volume>93</volume><fpage>1227</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">11682403</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Xiang</surname><given-names>H</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Cao</surname><given-names>D</given-names></name><name><surname>Ye</surname><given-names>L</given-names></name></person-group><article-title>Prediction of effect-site concentration of sufentanil by dose-response target controlled infusion of sufentanil and propofol for analgesic and sedation maintenance in burn dressing changes</article-title><source>Burns</source><year>2014</year><volume>40</volume><fpage>455</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">23993735</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akarsu</surname><given-names>Ayazo&#x0011f;lu T</given-names></name><name><surname>Polat</surname><given-names>E</given-names></name><name><surname>Bolat</surname><given-names>C</given-names></name><name><surname>Yasar</surname><given-names>NF</given-names></name><name><surname>Duman</surname><given-names>U</given-names></name><name><surname>Akbulut</surname><given-names>S</given-names></name><etal/></person-group><article-title>Comparison of propofol-based sedation regimens administered during colonoscopy</article-title><source>Rev Med Chil</source><year>2013</year><volume>141</volume><fpage>477</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">23900369</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joo</surname><given-names>JD</given-names></name><name><surname>In</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>DW</given-names></name><name><surname>Jung</surname><given-names>HS</given-names></name><name><surname>Kang</surname><given-names>JH</given-names></name><name><surname>Yeom</surname><given-names>JH</given-names></name><etal/></person-group><article-title>The comparison of sedation quality, side effect and recovery profiles on different dosage of remifentanil patient-controlled sedation during breast biopsy surgery</article-title><source>Korean J Anesthesiol</source><year>2012</year><volume>63</volume><fpage>431</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">23198037</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DiPalma</surname><given-names>JA</given-names></name><name><surname>Herrera</surname><given-names>JL</given-names></name><name><surname>Weis</surname><given-names>FR</given-names></name><name><surname>Dark-Mezick</surname><given-names>DL</given-names></name><name><surname>Brown</surname><given-names>RS</given-names></name></person-group><article-title>Alfentanil for conscious sedation during colonoscopy</article-title><source>South Med J</source><year>1995</year><volume>88</volume><fpage>630</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">7777878</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jabbour-Khoury</surname><given-names>SI</given-names></name><name><surname>Dabbous</surname><given-names>AS</given-names></name><name><surname>Rizk</surname><given-names>LB</given-names></name><name><surname>Abou</surname><given-names>Jalad NM</given-names></name><name><surname>Bartelmaos</surname><given-names>TE</given-names></name><name><surname>El-Khatib</surname><given-names>MF</given-names></name><etal/></person-group><article-title>A combination of alfentanil-lidocaine-propofol provides better intubating conditions than fentanyl-lidocaine-propofol in the absence of muscle relaxants</article-title><source>Can J Anaesth</source><year>2003</year><volume>50</volume><fpage>116</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">12560299</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egan</surname><given-names>TD</given-names></name><name><surname>Minto</surname><given-names>CF</given-names></name><name><surname>Hermann</surname><given-names>DJ</given-names></name><name><surname>Barr</surname><given-names>J</given-names></name><name><surname>Muir</surname><given-names>KT</given-names></name><name><surname>Shafer</surname><given-names>SL</given-names></name></person-group><article-title>Remifentanil versus alfentanil: Comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers</article-title><source>Anesthesiology</source><year>1996</year><volume>84</volume><fpage>821</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">8638836</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nilsson</surname><given-names>LB</given-names></name><name><surname>Viby-Mogensen</surname><given-names>J</given-names></name><name><surname>M&#x000f8;ller</surname><given-names>J</given-names></name><name><surname>Fonsmark</surname><given-names>L</given-names></name><name><surname>&#x000d8;stergaard</surname><given-names>D</given-names></name></person-group><article-title>Remifentanil vs. alfentanil for direct laryngoscopy: A randomized study comparing two total intravenous anaesthesia techniques. TIVA for direct laryngoscopy</article-title><source>Acta Anaesthesiol Belg</source><year>2002</year><volume>53</volume><fpage>213</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">12461831</pub-id></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osborne</surname><given-names>GA</given-names></name><name><surname>Rudkin</surname><given-names>GE</given-names></name><name><surname>Curtis</surname><given-names>NJ</given-names></name><name><surname>Vickers</surname><given-names>D</given-names></name><name><surname>Craker</surname><given-names>AJ</given-names></name></person-group><article-title>Intra-operative patient-controlled sedation. Comparison of patient-controlled propofol with anaesthetist-administered midazolam and fentanyl</article-title><source>Anaesthesia</source><year>1991</year><volume>46</volume><fpage>553</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">1862894</pub-id></element-citation></ref></ref-list></back></article>